Jing Cao, Ph.D. Titles and Appointments Associate Professor School Medical School Department Pathology Biography Dr. Jing Cao is board certified by the American Board of Clinical Chemistry. She directs Clinical Chemistry, Metabolics and Point of Care testing at Children's Health. Education Medical School Anhui Medical University (2000) Internship The First Affiliated Hospital of Anhui Medical University (2001), Medicine Graduate School University of Minnesota College of Biological Sciences (2012), Biochemistry, Molecular Biology & Biophysics Fellowship University of Minnesota Medical Center (2015), Clinical Chemistry Research Interest Dr. Cao's research interest has been on the clinical utility of fatty acid, cholesterol and lipoprotein biomarkers in cardiovascular and metabolic diseases, diagnostic assays and devices for inborn errors of metabolism in pediatric patients and for neurological disorders. She is funded by the National Institute of Helath to study circulating biomarkers in brain injury and by the International Federation of Clinical Chemistry to study lipoprotein testing in cardiovascular disease management. Publications Featured Publications Modern Low-Density Lipoprotein Cholesterol Formulas Outperform Direct Methods in Patients with Hypertriglyceridemia and Low Levels of Low-Density Lipoprotein Cholesterol. Meeusen JW, Yi X, Cotten SW, Nielsen JB, Donato LJ, Jones PM, Muthukumar AR, Zubirán R, Remaley AT, Cao J, Clin Chem 2025 Sep Factors associated with lipid lowering therapy in the multi-ethnic study of atherosclerosis. Cao J, Guan W, Nomura SO, Bhatia HS, Garg PK, Tsai MY, Lipids Health Dis 2024 Nov 23 1 375 Newborn Screening: Current Practice and Our Journey over the Last 60 Years. Cao J, Pasquali M, Jones PM, J Appl Lab Med 2024 Mar Poor Humoral Response in Solid Organ Transplant Recipients following Complete mRNA SARS-CoV-2 Vaccination. Cao J, Liu X, Muthukumar A, Gagan J, Jones P, Zu Y, Clin Chem 2021 Aug Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma. Ning B, Huang Z, Youngquist BM, Scott JW, Niu A, Bojanowski CM, Zwezdaryk KJ, Saba NS, Fan J, Yin XM, Cao J, Lyon CJ, Li CZ, Roy CJ, Hu TY, Nat Nanotechnol 2021 Jul Performance of novel low-density lipoprotein-cholesterol calculation methods in predicting clinical and subclinical atherosclerotic cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis. Cao J, Remaley AT, Guan W, Devaraj S, Tsai MY, Atherosclerosis 2021 06 327 1-4 Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Cao J, Nomura SO, Steffen BT, Guan W, Remaley AT, Karger AB, Ouyang P, Michos ED, Tsai MY, J Clin Lipidol 2020 Jan - Feb 14 1 109-121.e5 Evaluation of Lipoprotein(a) Electrophoretic and Immunoassay Methods in Discriminating Risk of Calcific Aortic Valve Disease and Incident Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis. Cao J, Steffen BT, Guan W, Budoff M, Michos ED, Kizer JR, Post WS, Tsai MY, Clin. Chem. 2017 Nov 63 11 1705-1713 Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY, Clin Chem 2006 Dec 52 12 2265-72 Clinical Features and Risk Stratification of Multiple Myeloma Patients with COVID-19. Zheng R, Mieth K, Bennett C, Miller C, Anderson LD, Chen M, Cao J, Cancers (Basel) 2023 Jul 15 14 Results 1-10 of 11 1 2 Next Last Books Featured Books Chapter 23: Lipids and Lipoproteins. In Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics, 9th Edition Meeusen J, Cao J, Donato L, Remaley AT (2022). Elsevier Honors & Awards 2025 Cooper Award for outstanding contribution to the professionADLM Cardiovascular Health Division Professional Associations/Affiliations Academy of Diagnostics and Laboratory Medicine (2016) Association of Diagnostics and Laboratory Medicine (2004)
